新疆喀什地区“第八批省市优秀援疆干部人才”

美国Virginia Commonwealth University药理及毒理系“优秀博士后”

中华医学会消化内镜学分会消化道癌筛查协作组委员

中华医学会消化内镜学分会早癌协作组青年委员

中华医学会行为医学分会消化病学组副组长

国家消化道早癌防治中心联盟食管早癌专业组学组专家

广东省医药质量管理协会消化与消化内镜专业委员会副主委

广东省医师协会消化内镜分会常委

广东省中西医结合学会脾胃消化病专业委员会常委

广东省医疗行业协会消化内镜分会常委

美国肝脏病协会AASLD委员

擅长在消化道早期肿瘤的内镜下微创诊治、脂肪肝的临床诊治，熟练掌握ESD、ERCP、EUS等内镜“三E”操作。首创消化道早癌筛查“南海模式”，胃癌筛查数量和早癌检出率位居省内首位，获李兆申院士的高度赞扬。

主持国家自然科学基金1项，参与国家自然科学基金重点项目1项，主持省厅级基金5项，以第一或通讯作者发表SCI论文10余篇，核心期刊10余篇，专利4项。

消化道早癌、代谢性疾病、肠道菌群

1.Yao J, Chen Y#, Zhang L, et al. PH-responsive CuS/DSF/EL/PVP nanoplatform alleviates inflammatory bowel disease in mice via regulating gut immunity and microbiota.Acta Biomater.2024;178:265-286.

2.Li D, Chen Y#, Wan M, et al. Oral magnesium prevents acetaminophen-induced acute liver injury by modulating microbial metabolism.Cell Host Microbe. 2024;32(1):48-62.e9.

3.Huang J#, Du BR, Qiao WG, Huang SL, Xue LF, Deng L, Liang JM, Wang J, Li JY, Chen Y*. Endoscopic submucosal dissection training: evaluation of an ex vivo training model with continuous perfusion (ETM-CP) for hands-on teaching and training in China. Surg Endosc. 2023 Jun;37(6):4774-4783.

4.Xue L#, Deng Z, Luo W, He X, Chen Y*. Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial. Front Cell Infect Microbiol. 2022 Jul 4;12:759306.

5.Yu Chen#, Jason Kidd, Owais M Bhat, Xinxu Yuan, Jinni Hong, Xingxiang He, Pin-lan Li*. Suppression of Glucagon-like Peptide-1 Release by Inhibition of Intestinal NLRP3 Inflammasome Activation in Asc-/- and Nlrp3-/- Mice. Frontiers in Physiology,2019 Oct 1;10:1213.

6.Yu Chen#, Huanhuan Sun, Yang Bai, Fachao Zhi*. Gut dysbiosis-derivedexosomes trigger hepatic steatosis by transiting HMGB1 from intestinal to liver in mice. Biochem Biophys Res Commun. 2019,509(3):767-772.

7.Chen Y#, He X, Yuan X, Hong J, Bhat O, Li G, Li P, Guo J*. NLRP3 Inflammasome Formation and Activation in Nonalcoholic Steatohepatitis: Therapeutic Target for Antimetabolic Syndrome Remedy FTZ. Oxidative Medicine and Cellular Longevity. 2018; 2901871:1-13.

8.Zhong Hao-Jie#, Sun Huan-Huan, Xue Lan-Feng, Yang Wan-Ying, Chen Yu*. Comparison of hepatic features between Wilson disease cirrhosis and hepatitis B cirrhosis: a retrospective study in China. World J Gastroenterol. 2019,25(3):378-387.

9.Lan-Feng Xue#, Wen-Hui Luo, Li-Hao Wu, Xing-Xiang He, Harry Hua-Xiang Xia, Yu Chen*. Fecal Microbiota Transplantation for the Treatment of Nonalcoholic Fatty Liver Disease. Exploratory Research and Hypothesis in Medicine 2019;4(1):12-18.

10.郭钰佳,薛兰凤,陈羽*.案例报道：结直肠腺瘤家庭共患现象及因素分析[J].现代消化及介入诊疗,2023,28(09):1192-1195.

11.黄俊# 薛兰凤, 曾阳, 吴军, 乔伟光, 陈羽*.蓝激光内镜联动成像联合京都胃炎分类构建全科医生消化亚专长培训模式[J].现代消化及介入诊疗, 2021, 26(08):944-948.

12.陈羽#, 黄俊, 薛兰凤, 孙占军, 赵爱民, 白杨, 智发朝, 杜庆锋*.“南海模式”早期胃癌筛查策略在基层社区中的应用评价[J].现代消化及介入诊疗, 2021, 26(08):939-943.

13.卢志斌#, 林良兜, 黄俊, 马伟钦, 孙占军, 陈羽*.胃癌筛查指南在基层无症状人群的实施研究初探[J].现代消化及介入诊疗, 2021, 26(08):949-952.